Haibo Qiu

6.6k total citations · 1 hit paper
141 papers, 2.6k citations indexed

About

Haibo Qiu is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Haibo Qiu has authored 141 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Pulmonary and Respiratory Medicine, 41 papers in Gastroenterology and 37 papers in Surgery. Recurrent topics in Haibo Qiu's work include Gastric Cancer Management and Outcomes (42 papers), Gastrointestinal Tumor Research and Treatment (41 papers) and Sepsis Diagnosis and Treatment (17 papers). Haibo Qiu is often cited by papers focused on Gastric Cancer Management and Outcomes (42 papers), Gastrointestinal Tumor Research and Treatment (41 papers) and Sepsis Diagnosis and Treatment (17 papers). Haibo Qiu collaborates with scholars based in China, United States and Bangladesh. Haibo Qiu's co-authors include Rui‐Hua Xu, Su‐Mei Cao, Zhiwei Zhou, Xiaowei Sun, Yuanfang Li, Run Lin, Hui Zhang, Zunfu Ke, Weiling He and Yi Yang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Haibo Qiu

124 papers receiving 2.6k citations

Hit Papers

Cancer incidence, mortali... 2021 2026 2022 2024 2021 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020
    2021 598 citations Haibo Qiu, Su‐Mei Cao et al. Cancer Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haibo Qiu China 23 936 907 540 532 455 141 2.6k
Laleh G. Melstrom United States 31 694 0.7× 1.2k 1.4× 953 1.8× 608 1.1× 461 1.0× 147 2.9k
Ronac Mamtani United States 35 761 0.8× 1.4k 1.6× 1.2k 2.2× 1.1k 2.1× 379 0.8× 215 4.0k
Kun Yang China 30 1.7k 1.8× 804 0.9× 1.2k 2.2× 506 1.0× 315 0.7× 177 3.1k
Rune Erichsen Denmark 32 776 0.8× 1.3k 1.5× 1.6k 3.0× 364 0.7× 270 0.6× 154 4.3k
Jianling Bai China 30 630 0.7× 592 0.7× 458 0.8× 913 1.7× 450 1.0× 114 2.5k
Ping Li China 29 2.0k 2.1× 767 0.8× 1.2k 2.3× 506 1.0× 224 0.5× 267 3.4k
Hui Zhao United States 27 801 0.9× 822 0.9× 559 1.0× 491 0.9× 321 0.7× 198 2.6k
Linda X. Jin United States 26 692 0.7× 655 0.7× 908 1.7× 401 0.8× 137 0.3× 60 2.6k
Christos Damaskos Greece 25 404 0.4× 584 0.6× 511 0.9× 832 1.6× 281 0.6× 175 2.2k
F. W. Schildberg Germany 36 1.1k 1.2× 1.1k 1.2× 1.4k 2.6× 534 1.0× 506 1.1× 143 3.6k

Countries citing papers authored by Haibo Qiu

Since Specialization
Citations

This map shows the geographic impact of Haibo Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Qiu more than expected).

Fields of papers citing papers by Haibo Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haibo Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Qiu. The network helps show where Haibo Qiu may publish in the future.

Co-authorship network of co-authors of Haibo Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Haibo Qiu. A scholar is included among the top collaborators of Haibo Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibo Qiu. Haibo Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Nie, Run‐Cong, Xiaojiang Chen, Chengcai Liang, et al.. (2025). Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer. Cell Reports Medicine. 6(6). 102190–102190. 1 indexed citations
4.
5.
Li, Fuping, Haibo Qiu, Chenxi Li, et al.. (2024). Compressive resilience mechanism of ceramic nanofiber aerogels: From micro-scale to atomic-scale. Ceramics International. 51(7). 9387–9397.
6.
Diao, Xiayao, Chao Guo, Bowen Li, et al.. (2024). Cancer situation in China: an analysis based on the global epidemiological data released in 2024. Cancer Communications. 45(2). 178–197. 26 indexed citations
7.
Nie, Run‐Cong, Ya Ding, Shuqiang Yuan, et al.. (2024). Perioperative PD-1 antibody tislelizumab plus chemotherapy for locally advanced gastro-oesophageal junction cancer: A prospective, nonrandomized, open-label, phase II trial.. Journal of Clinical Oncology. 42(16_suppl). 4083–4083. 1 indexed citations
8.
9.
Zhong, Jieqiang, Ming Huang, Haibo Qiu, et al.. (2024). Simple endoglycosidase-assisted peptide mapping workflow for characterizing non-consensus n-glycosylation in therapeutic monoclonal antibodies. Journal of Pharmaceutical Sciences. 114(2). 1125–1132. 1 indexed citations
10.
Guo, Jianrong, Hong Yu, Dan Jiang, et al.. (2023). Transcriptomic study of gastrointestinal stromal tumors with liver metastasis. Frontiers in Genetics. 14. 1007135–1007135. 2 indexed citations
11.
Diao, Xiayao, Yi Zeng, Xiao‐Jiang Chen, et al.. (2023). Physical activity and cancer risk: a dose‐response analysis for the Global Burden of Disease Study 2019. Cancer Communications. 43(11). 1229–1243. 31 indexed citations
12.
Yuan, Shuqiang, Run‐Cong Nie, Yingbo Chen, et al.. (2023). Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer. Cancer Communications. 43(12). 1312–1325. 13 indexed citations
13.
Jin, Xiaoxiao, Yan Ding, Shihui Sun, et al.. (2021). Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8+ T cell responses in HLA-A transgenic mice. Cellular and Molecular Immunology. 18(12). 2588–2608. 25 indexed citations
14.
Qiu, Haibo, Su‐Mei Cao, & Rui‐Hua Xu. (2021). Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Communications. 41(10). 1037–1048. 598 indexed citations breakdown →
15.
Lin, Run, Hui Zhang, Yujie Yuan, et al.. (2020). Fatty Acid Oxidation Controls CD8+ Tissue-Resident Memory T-cell Survival in Gastric Adenocarcinoma. Cancer Immunology Research. 8(4). 479–492. 169 indexed citations
16.
Liu, Xuechao, Haibo Qiu, Zhiming Wu, et al.. (2018). A Novel Pathological Prognostic Score (PPS) to Identify “Very High-Risk” Patients: a Multicenter Retrospective Analysis of 506 Patients with High Risk Gastrointestinal Stromal Tumor (GIST). Journal of Gastrointestinal Surgery. 22(12). 2150–2157. 10 indexed citations
17.
Chen, Tao, Lili Xu, Liangying Ye, et al.. (2018). A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods. European Journal of Surgical Oncology. 45(6). 1109–1114. 17 indexed citations
18.
Chen, Weicai, Ye Kuang, Haibo Qiu, et al.. (2017). Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors. Cancer Research. 77(18). 5107–5117. 28 indexed citations
19.
Qiu, Haibo, Peng Zhang, Xingyu Feng, et al.. (2016). [Changes of diagnosis and treatment for gastrointestinal stromal tumors during a 18-year period in four medical centers of China].. PubMed. 19(11). 1265–1270. 1 indexed citations
20.
Chen, Qihong, Yi Yang, Hongli He, et al.. (2014). The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials. Critical Care. 18(1). R8–R8. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laleh G. Melstrom Breakdown of academic impact, for papers by Ronac Mamtani Breakdown of academic impact, for papers by Kun Yang Breakdown of academic impact, for papers by Rune Erichsen Breakdown of academic impact, for papers by Jianling Bai Breakdown of academic impact, for papers by Ping Li Breakdown of academic impact, for papers by Hui Zhao Breakdown of academic impact, for papers by Linda X. Jin Breakdown of academic impact, for papers by Christos Damaskos Breakdown of academic impact, for papers by F. W. Schildberg
Rankless by CCL
2026